Propensity Score Analysis Comparing Videothoracoscopic Lobectomy With Thoracotomy: A French Nationwide Study

Pagès, Pierre-Benoît; Delpy, Jean-Philippe; Orsini, Bastien; Gossot, Dominique; Baste, Jean-Marc; Thomas, Philippe; Dahan, M.; Bernard, Alain

doi:10.1016/j.athoracsur.2015.10.105

Cited by 59 publications

(47 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The VATS approach obviates the need for division of chest wall muscles or rib spreading. Advocates for VATS lobectomy have previously emphasized the benefits of decreased post‐operative pain, early chest tube removal and shorter hospital stay . In the present study, we observed a significantly shorter mean hospital length of stay in the VATS group compared with the OT group.…”

Section: Discussionsupporting

confidence: 59%

Outcomes of video‐assisted thoracoscopic surgery lobectomy in septuagenarians

Fong

McLaughlin

et al. 2020

ANZ Journal of Surgery

View full text Add to dashboard Cite

Background: Spread of technology and increased surveillance have led to more patients with lung cancers being identified than ever before. Increasingly, patients from the elderly population are referred for surgery; however, many studies do not focus on this patient group. We reviewed the outcomes of septuagenarians who underwent lobectomy via an open thoracotomy (OT) or video-assisted thoracoscopic surgery (VATS) approach to determine whether the VATS approach would result in superior post-operative outcomes. Methods: Between January 2010 and June 2016, a total of 96 patients aged 70 years or older underwent a lobectomy for non-small cell lung carcinoma. Patients who underwent resection for metastatic disease, small cell lung cancer or neuroendocrine tumour were excluded. Demographic details, early and late post-operative outcomes including postoperative arrhythmia, myocardial infarction, respiratory failure, cerebrovascular events, infection, prolonged air leak, delirium, readmission and 30-day mortality were studied. Mean follow-up duration was 23 AE 19.1 months. Results: Seventy-five patients underwent lobectomy via a VATS approach and 21 patients underwent lobectomy via an OT approach. There was no 30-day mortality and no difference in overall survival between the two techniques (P = 0.25). There was no significant difference between the two techniques with regard to post-operative stroke, myocardial infarction, atrial fibrillation, pneumonia, delirium or bronchopleural fistula. VATS patients had a significantly shorter mean hospital length of stay (VATS 4.7 days, OT 9.3 days, P = 0.005). Conclusion: Septuagenarians with non-small cell lung carcinoma can successfully undergo curative lung resection with a low incidence of post-operative complications.© 2020 Royal Australasian College of Surgeons ANZ J Surg 90 (2020) 752-756ANZJSurg.com

show abstract

Section: Discussionsupporting

confidence: 59%

Outcomes of video‐assisted thoracoscopic surgery lobectomy in septuagenarians

Fong

McLaughlin

et al. 2020

ANZ Journal of Surgery

View full text Add to dashboard Cite

show abstract

“…Some studies using large national or regional databases have reported that VATS had a lower incidence of postoperative complications or shorter length of hospital stay by 1 to 2 days, but there is uncertainty as to whether this is clinically meaningful. [93][94][95][96] On the other hand, some reports concluded that a higher incidence of nodal upstaging has been observed in thoracotomy than in VATS, indicating the possibility of insufficient nodal evaluation in VATS. 97,98 Of note, these conclusions were derived from retrospective studies; therefore, they always harbor hidden biases that may affect the outcome.…”

Section: Tnm Staging Systemmentioning

confidence: 99%

Scientific Advances in Thoracic Oncology 2016

Soo

Cummings

Jett

et al. 2017

Journal of Thoracic Oncology

View full text Add to dashboard Cite

Lung cancer care is rapidly changing with advances in genomic testing, the development of next-generation targeted kinase inhibitors, and the continued broad study of immunotherapy in new settings and potential combinations. The International Association for the Study of Lung Cancer and the Journal of Thoracic Oncology publish this annual update to help readers keep pace with these important developments. Experts in thoracic cancer and care provide focused updates across multiple areas, including prevention and early detection, molecular diagnostics, pathology and staging, surgery, adjuvant therapy, radiotherapy, molecular targeted therapy, and immunotherapy for NSCLC, SCLC, and mesothelioma. Quality and value of care and perspectives on the future of lung cancer research and treatment have also been included in this concise review.

show abstract

“…When compared to lobectomy via thoracotomy, VATS has improved short-term outcomes: it is associated with a lower incidence of post-operative complications, shorter hospitalization, shorter duration of chest tube, and similar or lower rates of postoperative mortality (5)(6)(7)(8)(9)(10)(11)(12)(13)(14).…”

Section: Vatsmentioning

confidence: 99%